SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-24-073909
Filing Date
2024-06-21
Accepted
2024-06-21 16:02:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2417766d1_sc13d.htm SC 13D 38537
  Complete submission text file 0001104659-24-073909.txt   39899
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Subject) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92695 | Film No.: 241060087
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TRANSCODE THERAPEUTICS, INC. 6 LIBERTY SQUARE, #2382 BOSTON MA 02109
Business Address
Fitzgerald Thomas A (Filed by) CIK: 0001854168 (see all company filings)

Type: SC 13D